What You Should Know
- Surescripts has expanded its Prior Authorization Automation solution, increasing the number of enabled clinicians by 50% since December 2025 to reach 68,000 prescribers across 42 major health systems.
- Automated prior authorization systems achieved a median approval time of just 18 seconds when clinical determination criteria were met, bypassing traditional manual forms, faxes, and telephone calls.
- Real-Time Prescription Benefit tools saved patients $19.7 million from January through April 2026 alone, with average savings reaching $817 per specialty prescription and $100.58 per diabetic therapy.
- The solution directly counteracts a steep decline in care access, addressing industry data showing that only 55% of Americans can readily afford basic healthcare and prescribed medicines.
- Adoption of these point-of-care tools is poised to accelerate rapidly under the sweeping new CMS Interoperability and Prior Authorization proposed rule (CMS-0062-P).
Surescripts Expands Prior Authorization Automation: Slashing Prescription Approval Times as New CMS Interoperability Rules Loom
The administrative and economic friction defining the modern prescription pipeline has reached a critical tipping point. Across the United States, patients and care teams are navigating an increasingly complex care delivery matrix where cost and coverage barriers frequently dictate health outcomes. According to the West Health-Gallup Affordability Index, only 55% of Americans can readily access and afford basic healthcare and prescribed medications—a measurable decline from previous years.
At the center of this affordability crisis sits the traditional prior authorization process. Long criticized as a manual maze of paper forms, clunky faxes, and prolonged telephone hold times, the legacy authorization framework actively undercuts clinical velocity. In recent market surveys, 87% of pharmacists and 89% of prescribers stated that prior authorization requirements directly damage patient health outcomes, while nearly half of all prescribers report that these administrative hurdles frequently prevent them from ordering necessary therapies altogether. The result is a broken patient experience marred by sticker shock at the pharmacy counter, severe treatment anxiety, and a high rate of outright prescription abandonment.
To fundamentally streamline this bottleneck, Surescripts, the nation’s leading health intelligence network, has announced the rapid expansion of its Prior Authorization Automation and Real-Time Prescription Benefit infrastructure. Since December 2025, the number of providers enabled with Surescripts’ automation tools has surged by 50%, now totaling 68,000 active prescribers across 42 health systems, with an additional 119,000 clinicians scheduled to go live later this year.
Moving from Paperwork to 18-Second Approvals
The core value of Surescripts’ updated infrastructure lies in its ability to transition prior authorization from a reactive, retrospective scramble into a seamless, electronic “system of action” executed at the point of care.
Instead of requiring manual chart extraction or administrative data entry, Prior Authorization Automation integrates directly within existing Electronic Health Record (EHR) e-prescribing workflows. The software automatically retrieves required clinical documentation from the patient’s record, cross-references it against specific payer determination criteria, and sends it directly to the Pharmacy Benefit Manager (PBM).
When the clinical documentation matches the pre-established criteria, the request is processed and authorized without human intervention. Surescripts’ latest network data illustrates the immediate operational impact of this shift:
- 18-Second Median Approval Time: Prior authorizations that historically consumed days or weeks are now resolved in seconds.
- Decreased Friction: Health systems utilizing the platform report an 11% lower rate of denials due to missing information, alongside a 17% reduction in medical appeals.
- Expanding Drug Scope: The platform has expanded its clinical footprint to support 104 distinct medications, up from 40 in 2024, yielding a 34% automated approval rate for in-scope therapies.
When a prescription falls outside automated parameters, clinicians can utilize Electronic Prior Authorization (ePA) to bring localized payer question sets directly into their workspace, driving a 26.1% year-over-year increase in electronic processing for complex specialty medications.
Point-of-Care Pricing Transparency and Financial Return
Beyond speed, the optimization of the prescribing interface hinges on real-time price transparency. Through the Real-Time Prescription Benefit tool, providers can see exactly what a patient’s plan covers, what their out-of-pocket copay will be at their chosen pharmacy, and whether a prior authorization restriction is active before the script is ever transmitted. This immediate visibility allows clinicians to pivot to lower-cost, covered therapeutic alternatives in seconds.
In 2025 alone, prescribers used this benefit intelligence tool 1 billion times, saving patients $55.1 million. Data from the first four months of 2026 shows that patient savings are on pace to far exceed previous benchmarks, already locking in $19.7 million in savings from January through April.
On average, the tool saves patients $77 per standard prescription and $817 per specialty prescription when used to find a lower-cost substitute. Surescripts’ analysis across specific therapeutic classes between January and April 2026 highlights substantial localized relief, with average per-prescription savings reaching $193.85 for antipsychotics, $179.90 for non-opioid anti-inflammatories, and $100.58 for critical diabetic therapies. This financial mitigation drives a direct clinical return: a 2025 study demonstrated that medication adherence was 3.4% higher among diabetes patients whose providers utilized real-time benefit transparency.
